Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celera Genomics (CRA) -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (347)	5/11/2000 9:47:00 AM
From: gao seng	Respond to of 746

First of all, thanks for the article. It provided insight into recent gene count debate. Secondly, you are right. INCY has been wanting all along to help the HGP. When I first read the article on the conspiracy, I thought Incyte was trying to stay independent and were like a dark horse in the race. Now that I reread it, i see that they are selling their services to anyone who needs them, and are not to be considered as a competitor at all. They are more of a DoublTwist or GNSL than a Celera. But I am interested to learn more about gene count. I will research that this weekend. If INCY is right, then the latest news on Chromosome 21 is a fraud. Good Link to Gene Therapy - The Future is Here! medicinenet.com